The Ministry of Higher Education, Research and Innovation, the Ministry of Solidarity and Health, Inserm, PSL University (Paris Sciences et Lettres), Inria, the Agence du Numérique en Santé, and the Health Data Hub, together with all the players in the Paris region in the fields of training, research and care, have worked to create a digital health research and innovation campus, PariSanté Campus. In early March, the first class of PariSanté Campus start-ups was made official in the presence of Cédric O, Secretary of State for Digital Transition and Electronic Communications, and Clara Chappaz, Director of French Tech.
On June 29, Emmanuel Macron presented a plan, based on the work of the Strategic Council of Health Industries (CSIS), designed to make France “the leading European nation in innovation and sovereignty in health.” This plan, ” Innovation Santé 2030 “ with a budget of €7.5 billion, aims to ” innovate, invent, manufacture and sell to the world the healthcare products and solutions of tomorrow.” It is with this objective in mind that PariSanté Campus was created. Cédric O explains:
” In order to achieve this ambitious goal, the Government has notably put in place two pillars in the field of digital health: a “Digital Health” acceleration strategy to bring out tomorrow’s champions in digital health and a place that symbolizes this ambition, PariSanté Campus,which is now hosting its first class of startups and is gradually rolling out its service offering. “
PariSanté Campus was inaugurated on December 14 by Prime Minister Jean Castex. Located on a 20,000 square meter site in Issy-Les Moulineaux, just outside Paris, the center brings together the founding members, who have been joined by four research institutes: PRAIRIE (artificial intelligence and its uses in healthcare), the Q-Bio center (quantitative biology for modeling and predicting living systems), IPM (innovative ultrasound imaging) and ISNuS (ethical, sociological, economic and philosophical issues related to healthcare data). 3,000 people will work there.
The campus provides start-ups and companies with premises, skills, expertise and databases to accelerate their development.
Since its creation, it has launched two calls for applications and a committee has selected
60 startups from among hundreds of applications.
The 1st class of PariSanté Campus
This means that 60 startups will be able to access the entire digital health ecosystem of PariSanté Campus. Antoine Tesniere, Managing Director of PariSanté Campus, said:
” PariSanté Campus is particularly pleased to unveil today the 60 startups that will integrate the 1st promotion within this exceptional group. Whether in medical devices, digital therapies, artificial intelligence, data, patient platforms, or care pathways, they are all proposing solutions that will transform the healthcare of tomorrow, using data as a key element for creating value and impact. “
The startups selected in the artificial intelligence category are:
- CAERUS MEDICAL ‘s mission is to provide caregivers with digital spine solutions for optimal patient pathways.
To this end, the startup is developing a platform to help diagnose low back pain that integrates artificial intelligence (AI) and MRI from conventional Patient management. It is a medical grading tool for general radiologists that promotes a reliable and exhaustive diagnosis in just a few clicks. The proprietary AI algorithms are trained by a committee of international clinical experts in the fields of spinal surgery and radiology
and musculoskeletal radiology. The CAERUS MEDICAL team aims to improve patient care for a major public health issue: back pain. The underlying pathologies cause a considerable socio-economic impact. The diagnosis of these pathologies is particularly complex and gives rise to a variability of diagnosis which can imply a loss of efficiency in the patient pathway.
- CIBILTECH aims to demonstrate that France is capable of creating digital health startups by successfully transferring world-class algorithmic technologies.
Cibiltech publishes predictive health software solutions that assess the risk of graft loss in transplant patients. Doctors can thus be alerted to take action to ensure graft survival and enable patients to live better. In addition, the start-up is developing a technology capable of accelerating the development of new immunosuppressive drugs.
- CLINITYX is a technology company specialized in RWD and SNDS: epidemiology, collection, structuring, analysis and machine learning. For the pharmaceutical and medtech industries, in partnership with academics, Clinityx develops an innovative, secure and sovereign RWE platform: matched health data warehouse, patient transparency portal and RWD/SNDS datavisualization. Nicolas Glatt, its CEO, states:
“By bringing together a multitude of complementary expertise in a single location, PariSanté Campus will enable us to strengthen our synergies with players in the digital health ecosystem and the relevance of our work. We hope to be able to share our energy and develop our collaborations there. “
- KEENTURTLE is creating the new standards for medication safety.
Whether taken alone or in combination, drugs can have more or less serious adverse effects on a person’s health. This risk is called drug iatrogeny.
Keenturtle has developed PharmaClass®, a personalized and contextualized clinical decision support system that enables the detection of truly relevant alerts, a prioritization of risks among patients, with the prospect of significantly reducing the numbers of iatrogenia, with e-Health actors and health professionals.
This solution has already proven itself and been adopted in various university hospitals: Lille, Amiens, Paris, Nancy, Marseille, Brussels, Neuchâtel and Lausanne. During an interview with BFMTV, François Versini, Founder and CEO of Keenturtle, declared:
” We should not think that it is a problem of competence of the doctor, or that the pharmacist has a lack of expertise, far from it. We have extraordinary competence in France. It is the computerization that has been too compartmentalized and has reproduced too many historical processes. It is with a new digitalization that we can change the game. “
- MAGIC LEMP, a company specializing in research and development in trusted Artificial Intelligence, has placed health at the heart of its activities.
Its CaPrICoRN project was the winner of the AI for Health 2021 Challenge and focused on the classification of bronchopulmonary cancers using multimodal data.
Raphaël-David Lasseri, president and founder of Magic LEMP, said at the time:
” One year after being a winner of the IA4Curie Challenge, we are delighted with this new recognition of our CaPrICoRN project aimed at better predicting the response to immunotherapy treatment of bronchial cancer patients using AI. “
Today, he is pleased with his start-up’s integration into PariSanté Campus:
” PariSanté Campus is an opportunity for Magic LEMP to benefit from a stimulating ecosystem while bringing its cutting-edge expertise in explainable AI via consulting or training. “
- MINDPULSE is currently the only test that assesses the speed/accuracy/variability decision balance of attentional and executive functions.
With its complex algorithms analyzing data captured during a 15-minute test, MindPulse provides a comprehensive and accurate overview of attentional and executive functions with 16 indicators. Three minutes after the test is completed, the clinician accesses a detailed report with a visual summary reflecting the balance of fundamental decision making.
This digital test, intended for professionals in the field of cognition (joint patent CNRS / Université Paris-Saclay / IT’S BRAIN), allows for regular follow-up, which is possible by teleconsultation. A program of clinical trials and research underway will demonstrate the potential in clinical (depression, long COVID …) and will allow with AI to identify diagnostic profiles (neurodevelopmental disorders, degenerative diseases …) and move towards a precision mental health.
Guillaume Simon, Managing Director, CEO of MINDPULSE, states:
” Parisanté Campus corresponds to a real need to facilitate exchanges between e-health players and interactions with institutions. “
- RAIDIUM is a MEDTECH startup of artificial intelligence in medical imaging, composed of two ex-employees of Owkin Unicorn.
Both seek to build a transversal platform to support the medical imaging workflow, based on the meeting of a new generation interoperable viewer that supports a range of
The two companies are looking to build a cross-functional workflow support platform for medical imaging, based on the combination of a next-generation interoperable viewer that supports a range of AI/deeplearning algorithms applied to 3D imaging. Paul Hérent, CEO of Raidium, states:
” With Raidium, our Medtech startup, we are very happy to have been selected to participate in the PariSanté Campus adventure to accomplish our mission: putting artificial intelligence at the service of medical imaging. Being able to evolve in a health-oriented ecosystem seems strategic to us at our various stages of development. “
In the “drug discovery” category:
- One Biosciences.
Medical Devices and Connected Objects” category:
- Avatar Medical
- Let it care
Responsible Data” category:
- Netis AI
Clinical Trials category:
The “training” category:
The “organizational innovation” category:
- Conex Health
- H24 Care
- Urgences Chrono.
The “Data Platform” category:
- Cortexx Medical Intelligence
The “service” category:
The “digital therapies” category:
The category “actors participating in the gas pedal”:
- Clin’s MD
- Doshas Consulting
- La Forge
- Lerins & BCW
- Metropolo Advisory
- Okantis (ex SILPC)